Venous thromboembolism prevention in acutely III nonsurgical patients

Donald F. Brophy, John A. Dougherty, James C. Garrelts, Roy C. Parish, Michael P. Rivey, Janice L. Stumpf, Charles Thomas Taylor, A. Scott Mathis

Research output: Contribution to journalReview articleResearchpeer-review

5 Citations (Scopus)

Abstract

OBJECTIVE: To review recent advances in the prevention of venous thromboembolism (VTE) in acutely ill nonsurgical inpatients. DATA SOURCES: A MEDLINE search (1966-March 2005) was done to identify relevant articles relating to prevention of VTE in acutely ill nonsurgical inpatients. STUDY SELECTION AND DATA EXTRACTION: Four major prophylaxis trials, one registry, one guideline, and supporting articles representative of the subject matter from the last few years were included. DATA SYNTHESIS: Enoxaparin, dalteparin, fondaparinux, and unfractionated heparin 5000 units every 8 hours are effective in reducing the risk of VTE in acutely ill medical patients, but such prophylaxis is currently underused. Barriers to be overcome include recognition of the importance of VTE in this population, definition of the optimal strategy to assess risks, optimal timing of the risk assessment, optimal prophylactic regimen for a given level of risk or disease state, and optimal duration of prophylaxis. We recommend that acutely ill medical inpatients should be risk-stratified early in their hospitalization. At this time, the specific risk-assessment protocol should be derived from the trial(s) of the available formulary agent(s). Decisions about providing prophylaxis must also be made considering anticoagulant contraindications and renal function. Mechanical methods of prophylaxis should be considered as monotherapy only if an anticoagulant contraindication exists. The optimal duration of prophylaxis is not known, but 14 days was used in recent studies. CONCLUSIONS: Prophylaxis of VTE in acutely ill medical inpatients is underused. Data provide some guidance for increasing awareness and optimizing patient care.

Original languageEnglish
Pages (from-to)1318-1324
Number of pages7
JournalAnnals of Pharmacotherapy
Volume39
Issue number7-8
DOIs
StatePublished - 1 Jul 2005

Fingerprint

Venous Thromboembolism
Inpatients
Anticoagulants
Dalteparin
Formularies
Enoxaparin
MEDLINE
Registries
Heparin
Patient Care
Hospitalization
Guidelines
Kidney
Population

Keywords

  • Anticoagulants: Fondaparinux, heparin, low-molecular-weight heparin
  • Deep vein thrombosis
  • Prophylaxis

Cite this

Brophy, D. F., Dougherty, J. A., Garrelts, J. C., Parish, R. C., Rivey, M. P., Stumpf, J. L., ... Mathis, A. S. (2005). Venous thromboembolism prevention in acutely III nonsurgical patients. Annals of Pharmacotherapy, 39(7-8), 1318-1324. https://doi.org/10.1345/aph.1G127
Brophy, Donald F. ; Dougherty, John A. ; Garrelts, James C. ; Parish, Roy C. ; Rivey, Michael P. ; Stumpf, Janice L. ; Taylor, Charles Thomas ; Mathis, A. Scott. / Venous thromboembolism prevention in acutely III nonsurgical patients. In: Annals of Pharmacotherapy. 2005 ; Vol. 39, No. 7-8. pp. 1318-1324.
@article{bfefaddc91b24d9e88221c4c0eb7a675,
title = "Venous thromboembolism prevention in acutely III nonsurgical patients",
abstract = "OBJECTIVE: To review recent advances in the prevention of venous thromboembolism (VTE) in acutely ill nonsurgical inpatients. DATA SOURCES: A MEDLINE search (1966-March 2005) was done to identify relevant articles relating to prevention of VTE in acutely ill nonsurgical inpatients. STUDY SELECTION AND DATA EXTRACTION: Four major prophylaxis trials, one registry, one guideline, and supporting articles representative of the subject matter from the last few years were included. DATA SYNTHESIS: Enoxaparin, dalteparin, fondaparinux, and unfractionated heparin 5000 units every 8 hours are effective in reducing the risk of VTE in acutely ill medical patients, but such prophylaxis is currently underused. Barriers to be overcome include recognition of the importance of VTE in this population, definition of the optimal strategy to assess risks, optimal timing of the risk assessment, optimal prophylactic regimen for a given level of risk or disease state, and optimal duration of prophylaxis. We recommend that acutely ill medical inpatients should be risk-stratified early in their hospitalization. At this time, the specific risk-assessment protocol should be derived from the trial(s) of the available formulary agent(s). Decisions about providing prophylaxis must also be made considering anticoagulant contraindications and renal function. Mechanical methods of prophylaxis should be considered as monotherapy only if an anticoagulant contraindication exists. The optimal duration of prophylaxis is not known, but 14 days was used in recent studies. CONCLUSIONS: Prophylaxis of VTE in acutely ill medical inpatients is underused. Data provide some guidance for increasing awareness and optimizing patient care.",
keywords = "Anticoagulants: Fondaparinux, heparin, low-molecular-weight heparin, Deep vein thrombosis, Prophylaxis",
author = "Brophy, {Donald F.} and Dougherty, {John A.} and Garrelts, {James C.} and Parish, {Roy C.} and Rivey, {Michael P.} and Stumpf, {Janice L.} and Taylor, {Charles Thomas} and Mathis, {A. Scott}",
year = "2005",
month = "7",
day = "1",
doi = "10.1345/aph.1G127",
language = "English",
volume = "39",
pages = "1318--1324",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "SAGE Publications Inc.",
number = "7-8",

}

Brophy, DF, Dougherty, JA, Garrelts, JC, Parish, RC, Rivey, MP, Stumpf, JL, Taylor, CT & Mathis, AS 2005, 'Venous thromboembolism prevention in acutely III nonsurgical patients', Annals of Pharmacotherapy, vol. 39, no. 7-8, pp. 1318-1324. https://doi.org/10.1345/aph.1G127

Venous thromboembolism prevention in acutely III nonsurgical patients. / Brophy, Donald F.; Dougherty, John A.; Garrelts, James C.; Parish, Roy C.; Rivey, Michael P.; Stumpf, Janice L.; Taylor, Charles Thomas; Mathis, A. Scott.

In: Annals of Pharmacotherapy, Vol. 39, No. 7-8, 01.07.2005, p. 1318-1324.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Venous thromboembolism prevention in acutely III nonsurgical patients

AU - Brophy, Donald F.

AU - Dougherty, John A.

AU - Garrelts, James C.

AU - Parish, Roy C.

AU - Rivey, Michael P.

AU - Stumpf, Janice L.

AU - Taylor, Charles Thomas

AU - Mathis, A. Scott

PY - 2005/7/1

Y1 - 2005/7/1

N2 - OBJECTIVE: To review recent advances in the prevention of venous thromboembolism (VTE) in acutely ill nonsurgical inpatients. DATA SOURCES: A MEDLINE search (1966-March 2005) was done to identify relevant articles relating to prevention of VTE in acutely ill nonsurgical inpatients. STUDY SELECTION AND DATA EXTRACTION: Four major prophylaxis trials, one registry, one guideline, and supporting articles representative of the subject matter from the last few years were included. DATA SYNTHESIS: Enoxaparin, dalteparin, fondaparinux, and unfractionated heparin 5000 units every 8 hours are effective in reducing the risk of VTE in acutely ill medical patients, but such prophylaxis is currently underused. Barriers to be overcome include recognition of the importance of VTE in this population, definition of the optimal strategy to assess risks, optimal timing of the risk assessment, optimal prophylactic regimen for a given level of risk or disease state, and optimal duration of prophylaxis. We recommend that acutely ill medical inpatients should be risk-stratified early in their hospitalization. At this time, the specific risk-assessment protocol should be derived from the trial(s) of the available formulary agent(s). Decisions about providing prophylaxis must also be made considering anticoagulant contraindications and renal function. Mechanical methods of prophylaxis should be considered as monotherapy only if an anticoagulant contraindication exists. The optimal duration of prophylaxis is not known, but 14 days was used in recent studies. CONCLUSIONS: Prophylaxis of VTE in acutely ill medical inpatients is underused. Data provide some guidance for increasing awareness and optimizing patient care.

AB - OBJECTIVE: To review recent advances in the prevention of venous thromboembolism (VTE) in acutely ill nonsurgical inpatients. DATA SOURCES: A MEDLINE search (1966-March 2005) was done to identify relevant articles relating to prevention of VTE in acutely ill nonsurgical inpatients. STUDY SELECTION AND DATA EXTRACTION: Four major prophylaxis trials, one registry, one guideline, and supporting articles representative of the subject matter from the last few years were included. DATA SYNTHESIS: Enoxaparin, dalteparin, fondaparinux, and unfractionated heparin 5000 units every 8 hours are effective in reducing the risk of VTE in acutely ill medical patients, but such prophylaxis is currently underused. Barriers to be overcome include recognition of the importance of VTE in this population, definition of the optimal strategy to assess risks, optimal timing of the risk assessment, optimal prophylactic regimen for a given level of risk or disease state, and optimal duration of prophylaxis. We recommend that acutely ill medical inpatients should be risk-stratified early in their hospitalization. At this time, the specific risk-assessment protocol should be derived from the trial(s) of the available formulary agent(s). Decisions about providing prophylaxis must also be made considering anticoagulant contraindications and renal function. Mechanical methods of prophylaxis should be considered as monotherapy only if an anticoagulant contraindication exists. The optimal duration of prophylaxis is not known, but 14 days was used in recent studies. CONCLUSIONS: Prophylaxis of VTE in acutely ill medical inpatients is underused. Data provide some guidance for increasing awareness and optimizing patient care.

KW - Anticoagulants: Fondaparinux, heparin, low-molecular-weight heparin

KW - Deep vein thrombosis

KW - Prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=21744453501&partnerID=8YFLogxK

U2 - 10.1345/aph.1G127

DO - 10.1345/aph.1G127

M3 - Review article

VL - 39

SP - 1318

EP - 1324

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 7-8

ER -

Brophy DF, Dougherty JA, Garrelts JC, Parish RC, Rivey MP, Stumpf JL et al. Venous thromboembolism prevention in acutely III nonsurgical patients. Annals of Pharmacotherapy. 2005 Jul 1;39(7-8):1318-1324. https://doi.org/10.1345/aph.1G127